COVID-19 Outcomes in Lung Transplant Recipients Following Pre-Exposure Prophylaxis With Tixagevimab-Cilgavimab During the Omicron BA.5 Surge: A Single Center Analysis.
Journal Information
Full Title: Transpl Int
Abbreviation: Transpl Int
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Transplantation
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Conflict of Interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be constructed as a potential conflict of interest."
"RV is supported by the Research Foundation-Flanders (FWO) as senior clinical researcher (1803521N) and by a research grant (G060322N). RV is supported by an academic research grant from AstraZeneca, but the study was conducted without Industry sponsorship."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025